Neurologic Manifestations of Common Variable Immunodeficiency: Impact on Quality of Life.

Bruno Ivo De AlmeidaTammy L SmithAlen DelicLawanda EsquibelJonathan GalliLeah MillsapM Mateo Paz SoldánMelissa M CortezJohn RoseJohn E GreenleeAdi V GundlapalliHarry R HillKa-Ho WongStacey L Clardy

Published in: Neurology(R) neuroimmunology & neuroinflammation (2023)

Among survey respondents, there is a marked burden of neurologic symptoms. Given the impact of neurologic symptoms on health-related quality-of-life measures, clinicians should screen patients with common variable immunodeficiency for the presence of these symptoms and offer referral to neurologists and/or symptomatic treatment when indicated. Frequently prescribed neurologic medications may also affect the immune system, and neurologists should consider screening patients for immune deficiency before prescribing them.

Keyphrases

primary care
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
sleep quality
prognostic factors
risk factors
patient reported outcomes
adverse drug